Access cutting-edge solid tumor treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access solid tumor specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumor treatment provided free
The primary objective of this study is to assess the safety and tolerability and to determine the recommended Phase 2 dose (RP2D) of E7386 in combination with other anticancer drug(s), and to determine the optimal dose of E7386 in combination with lenvatinib in endometrial carcinoma (EC) (for EC Dose Optimization Part only).
Sponsor: Eisai Inc.
Check if you qualify for this solid tumor clinical trial in Los Angeles, CA
If you're searching for solid tumor treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.